Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 1,133,416 | 1,171,642 | 1,295,299 | 1,230,626 | 1,058,385 |
| Cost of Goods | 748,656 | 748,650 | 796,478 | 752,435 | 651,778 |
| Gross Profit | 384,760 | 422,992 | 498,821 | 478,191 | 406,607 |
| Operating Expenses | 683,928 | 254,029 | 951,138 | 251,467 | 219,212 |
| Operating Income | -298,512 | 169,613 | -451,839 | 227,159 | 188,173 |
| Interest Expense | 35,279 | 21,682 | 22,335 | 24,453 | 19,426 |
| Other Income | -291 | 3,626 | 2,728 | 8,235 | 7,817 |
| Pre-tax Income | -334,082 | 151,557 | -471,446 | 210,941 | 176,564 |
| Income Tax | 23 | 40,354 | 57,029 | 56,677 | 49,738 |
| Net Income Continuous | -334,105 | 111,203 | -528,475 | 154,264 | 125,221 |
| Net Income Discontinuous | -8,012 | 1,399 | 3,283 | -3,146 | -181,004 |
| Minority Interests | -5,448 | -1,839 | -687 | 470 | N/A |
| Net Income | $-336,669 | $114,441 | $-524,505 | $150,648 | $-55,783 |
| EPS Basic Total Ops | -5.38 | 1.75 | -7.80 | 2.25 | -0.81 |
| EPS Basic Continuous Ops | -5.25 | 1.73 | -7.85 | 2.30 | 1.82 |
| EPS Basic Discontinuous Ops | -0.13 | 0.02 | 0.05 | -0.05 | -2.63 |
| EPS Diluted Total Ops | -5.38 | 1.74 | -7.80 | 2.19 | -0.80 |
| EPS Diluted Continuous Ops | -5.25 | 1.72 | -7.85 | 2.24 | 1.79 |
| EPS Diluted Discontinuous Ops | -0.13 | 0.02 | 0.05 | -0.05 | -2.59 |
| EBITDA(a) | $119,914 | $273,373 | $348,476 | $313,570 | $270,759 |